X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Strides Arcolab with Cadila Healthcare - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STRIDES SHASUN LTD vs CADILA HEALTHCARE - Comparison Results

STRIDES SHASUN LTD    Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

CADILA HEALTHCARE 
   Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STRIDES SHASUN LTD CADILA HEALTHCARE STRIDES SHASUN LTD/
CADILA HEALTHCARE
 
P/E (TTM) x 13.1 32.2 40.7% View Chart
P/BV x 1.5 6.0 25.4% View Chart
Dividend Yield % 0.7 0.8 82.9%  

Financials

 STRIDES SHASUN LTD   CADILA HEALTHCARE
EQUITY SHARE DATA
    STRIDES SHASUN LTD
Mar-17
CADILA HEALTHCARE
Mar-17
STRIDES SHASUN LTD/
CADILA HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs1,275460 277.1%   
Low Rs918305 301.0%   
Sales per share (Unadj.) Rs389.692.1 422.9%  
Earnings per share (Unadj.) Rs28.014.8 188.8%  
Cash flow per share (Unadj.) Rs48.918.5 264.6%  
Dividends per share (Unadj.) Rs4.503.20 140.6%  
Dividend yield (eoy) %0.40.8 49.1%  
Book value per share (Unadj.) Rs303.168.0 445.8%  
Shares outstanding (eoy) m89.421,023.74 8.7%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.84.2 67.8%   
Avg P/E ratio x39.225.8 151.8%  
P/CF ratio (eoy) x22.420.7 108.3%  
Price / Book Value ratio x3.65.6 64.3%  
Dividend payout %16.121.6 74.5%   
Avg Mkt Cap Rs m98,036391,581 25.0%   
No. of employees `0005.816.9 34.4%   
Total wages/salary Rs m5,88115,002 39.2%   
Avg. sales/employee Rs Th6,005.95,594.5 107.4%   
Avg. wages/employee Rs Th1,014.0890.1 113.9%   
Avg. net profit/employee Rs Th431.2899.9 47.9%   
INCOME DATA
Net Sales Rs m34,83494,295 36.9%  
Other income Rs m1,6861,286 131.1%   
Total revenues Rs m36,52095,581 38.2%   
Gross profit Rs m6,42819,036 33.8%  
Depreciation Rs m1,8723,750 49.9%   
Interest Rs m2,269450 504.3%   
Profit before tax Rs m3,97316,122 24.6%   
Minority Interest Rs m0338 0.0%   
Prior Period Items Rs m40-   
Extraordinary Inc (Exp) Rs m-1,006-3 33,523.3%   
Tax Rs m4701,289 36.5%   
Profit after tax Rs m2,50115,168 16.5%  
Gross profit margin %18.520.2 91.4%  
Effective tax rate %11.88.0 148.0%   
Net profit margin %7.216.1 44.6%  
BALANCE SHEET DATA
Current assets Rs m38,16560,223 63.4%   
Current liabilities Rs m30,40253,058 57.3%   
Net working cap to sales %22.37.6 293.3%  
Current ratio x1.31.1 110.6%  
Inventory Days Days7770 110.8%  
Debtors Days Days10488 118.5%  
Net fixed assets Rs m37,63972,984 51.6%   
Share capital Rs m8941,024 87.3%   
"Free" reserves Rs m26,21068,576 38.2%   
Net worth Rs m27,10569,600 38.9%   
Long term debt Rs m16,37724,684 66.3%   
Total assets Rs m81,168152,207 53.3%  
Interest coverage x2.836.8 7.5%   
Debt to equity ratio x0.60.4 170.4%  
Sales to assets ratio x0.40.6 69.3%   
Return on assets %5.910.3 57.3%  
Return on equity %9.221.8 42.3%  
Return on capital %12.117.9 67.2%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m13,46521,280 63.3%   
Fx outflow Rs m4,07610,874 37.5%   
Net fx Rs m9,38910,406 90.2%   
CASH FLOW
From Operations Rs m2,88113,495 21.4%  
From Investments Rs m-7,051-29,103 24.2%  
From Financial Activity Rs m3,38223,158 14.6%  
Net Cashflow Rs m-7887,556 -10.4%  

Share Holding

Indian Promoters % 27.7 74.8 37.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 37.8 8.3 455.4%  
FIIs % 8.6 5.9 145.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.9 11.0 235.5%  
Shareholders   56,241 44,069 127.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STRIDES SHASUN LTD With:   VENUS REMEDIES  ORCHID PHARMA LTD  SANOFI INDIA  J.B.CHEMICALS  SHASUN PHARMA  

Compare STRIDES SHASUN LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Lower; Energy & PSU Stocks Lose(09:30 am)

Asian stocks are lower today as Chinese and Hong Kong shares fall. The Shanghai Composite is off 1.67% while the Hang Seng is down 0.87%. The Nikkei 225 is trading down by 1.18%.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

The Foundation for Sensex 100,000 is Laid(The 5 Minute Wrapup)

Feb 17, 2018

Top three reasons for Tanushree's presentation at Equitymaster Conference to be centered around a possible 30% correction.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STRIDES SHASUN LTD SHARE PRICE


Feb 22, 2018 10:09 AM

TRACK STRIDES SHASUN LTD

  • Track your investment in STRIDES SHASUN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STRIDES SHASUN LTD

STRIDES SHASUN LTD 8-QTR ANALYSIS

COMPARE STRIDES SHASUN LTD WITH

MARKET STATS